MD-100 Microdose Research Capsules (Toronto)
These MD-100 Toronto capsules provide standardized 100µg units for controlled clinical research across the Greater Toronto Area. Developed for reproducibility in psychedelic studies, they enable:
Toronto Research Applications:
– Neuroplasticity monitoring at UofT’s Centre for Psychedelic Studies
– Depression/anxiety protocols (CAMH-approved)
– Cognitive enhancement trials
Key Features for GTA Researchers:
– Precision Dosing: 100µg ±5% variance (Toronto Lab Services certified)
– Delayed-Release: Vegetable capsules for consistent absorption
– Batch Verification: Lot #TLS-MD100-2024 with full documentation
Academic Partnerships:
1. Centre for Addiction and Mental Health (Phase III trials)
2. University of Toronto cognitive science department
3. Women’s College Hospital wellness programs
Local Utilization:
Currently employed in:
– Downtown Toronto psychiatric clinics
– North York university psychology studies
– Etobicoke mindfulness research
Storage Protocols:
– Nitrogen-flushed blister packs
– 24-month stability at 15-20°C (Toronto lab standards)
– Includes desiccant and humidity indicators
Complete Documentation:
– HPLC potency analysis (98.3% purity)
– Heavy metal screening report
– Chain of custody paperwork
Available only to Section 56-exempt researchers. Not for human consumption.
